IQVIA Life Science Models

AI model · Science / biology model by IQVIA

Predict clinical trial outcomes and simulate market dynamics with purpose-built life science models.

IQVIA Life Science Models are a suite of purpose-built predictive models designed for the life sciences industry to simulate outcomes across patients, clinical trials, and markets. Built using NVIDIA Nemotron technology and supported by AWS infrastructure, these models enable protocol optimization, digital twins, and synthetic controls. In initial evaluations across 50 trials, the models achieved an 85% accuracy rate for predictions. The solution helps organizations identify risks early, avoid costly rework, and accelerate the delivery of therapies by up to two years.

Architecture
NVIDIA Nemotron
Infrastructure
Amazon Web Services (AWS)
Predictive Accuracy
85% on target or clinically close
Evaluation Scope
50 trials and 270 endpoints

Overview

IQVIA Life Science Models are a suite of purpose-built predictive models designed for the life sciences industry to simulate outcomes across patients, clinical trials, and markets. Built using NVIDIA Nemotron technology and supported by AWS infrastructure, these models enable protocol optimization, digital twins, and synthetic controls. In initial evaluations across 50 trials, the models achieved an 85% accuracy rate for predictions. The solution helps organizations identify risks early, avoid costly rework, and accelerate the delivery of therapies by up to two years.

Clinical Development Simulation

  • Patient Simulation: Simulates patient journeys and clinical outcomes by connecting molecular and treatment information.
  • Digital Twins: Enables digital twins and synthetic controls to support more efficient study designs.
  • Protocol Optimization: Optimizes protocols by predicting endpoint selection, patient eligibility criteria, dose selection, and sample size planning.
  • Risk Identification: Identifies and removes risks early in the development cycle to prevent delays.

Commercial and Market Insights

  • Market Simulation: Simulates market dynamics to test commercial decisions before execution.
  • Real-World Planning: Leverages clinical study predictions to inform better real-world planning and access.
  • Decision Support: Simulates outcomes across patients, clinical trials, and markets to choose stronger options.

Model Architecture and Performance

  • Domain Expertise Integration: Combines proprietary expert content with deep domain knowledge and regulatory frameworks.
  • Predictive Accuracy: Achieved 85% accuracy in initial evaluations across 50 trials and 270 endpoints.

Specifications

Architecture
NVIDIA Nemotron
Infrastructure
Amazon Web Services (AWS)
Predictive Accuracy
85% on target or clinically close
Evaluation Scope
50 trials and 270 endpoints

Added by AntSpace from public sources (iqvia.com).

More AI models by IQVIA